COCHLEAR LTDCOCHLEAR LTDCOCHLEAR LTD

COCHLEAR LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪12.84 B‬EUR
‪183.54 M‬EUR
‪1.19 B‬EUR
‪61.97 M‬
Beta (1Y)
0.63

About COCHLEAR LIMITED

CEO
Diggory William Howitt
Headquarters
Sydney
Employees (FY)
‪4.8 K‬
Founded
1983
ISIN
AU000000COH5
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment deals with the treatment pathway for acquired or progressive hearing loss. The Services segment offers sound processor upgrades, accessories, and others. The Acoustic segment is for the bone conduction systems. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OC5 is 197.58 EUR — it has increased by 0.72% in the past 24 hours. Watch COCHLEAR LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange COCHLEAR LTD stocks are traded under the ticker OC5.
OC5 stock has fallen by 0.43% compared to the previous week, the month change is a 1.24% rise, over the last year COCHLEAR LTD has showed a 33.14% increase.
We've gathered analysts' opinions on COCHLEAR LTD future price: according to them, OC5 price has a max estimate of 224.15 EUR and a min estimate of 140.71 EUR. Watch OC5 chart and read a more detailed COCHLEAR LTD stock forecast: see what analysts think of COCHLEAR LTD and suggest that you do with its stocks.
OC5 reached its all-time high on Feb 23, 2024 with the price of 208.90 EUR, and its all-time low was 10.77 EUR and was reached on Aug 18, 2004. View more price dynamics on OC5 chart.
See other stocks reaching their highest and lowest prices.
OC5 stock is 0.72% volatile and has beta coefficient of 0.63. Track COCHLEAR LTD stock price on the chart and check out the list of the most volatile stocks — is COCHLEAR LTD there?
Today COCHLEAR LTD has the market capitalization of ‪12.85 B‬, it has decreased by 0.60% over the last week.
Yes, you can track COCHLEAR LTD financials in yearly and quarterly reports right on TradingView.
COCHLEAR LTD is going to release the next earnings report on Aug 15, 2024. Keep track of upcoming events with our Earnings Calendar.
OC5 earnings for the last quarter are 1.80 EUR per share, whereas the estimation was 1.76 EUR resulting in a 2.22% surprise. The estimated earnings for the next quarter are 1.88 EUR per share. See more details about COCHLEAR LTD earnings.
COCHLEAR LTD revenue for the last quarter amounts to ‪686.74 M‬ EUR despite the estimated figure of ‪682.20 M‬ EUR. In the next quarter revenue is expected to reach ‪715.37 M‬ EUR.
OC5 net income for the last quarter is ‪118.05 M‬ EUR, while the quarter before that showed ‪97.08 M‬ EUR of net income which accounts for 21.60% change. Track more COCHLEAR LTD financial stats to get the full picture.
COCHLEAR LTD dividend yield was 1.44% in 2023, and payout ratio reached 72.19%. The year before the numbers were 1.51% and 68.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 27, 2024, the company has ‪4.80 K‬ employees. See our rating of the largest employees — is COCHLEAR LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COCHLEAR LTD EBITDA is ‪353.55 M‬ EUR, and current EBITDA margin is 25.22%. See more stats in COCHLEAR LTD financial statements.
Like other stocks, OC5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COCHLEAR LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COCHLEAR LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COCHLEAR LTD stock shows the buy signal. See more of COCHLEAR LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.